|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Arachidonic acid metabolism in glucocorticoid-induced hypertension.
|
18067589 |
2008 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Antioxidant vitamins and adrenocorticotrophic hormone-induced hypertension in rats.
|
17994356 |
2007 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
BEFREE |
The correlation between excretion of aldosterone and cortisol metabolites and suggests that, in TT subjects, ACTH exerts an important common regulatory influence on adrenal corticosteroid production in subjects with hypertension.
|
17651452 |
2007 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
The aim of the present study was to investigate the effects of aspirin, a potent antioxidant, on adrenocorticotropic hormone (ACTH) and dexamethasone (Dex)-induced hypertension.
|
17954371 |
2007 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
The aim of the present study was to investigate the effects of aspirin, a potent antioxidant, on adrenocorticotropic hormone (ACTH) and dexamethasone (Dex)-induced hypertension.
|
17954371 |
2007 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Antioxidant vitamins and adrenocorticotrophic hormone-induced hypertension in rats.
|
17994356 |
2007 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
The ACTH and Dex hypertension were partially reversed by folic acid.
|
17324744 |
2007 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
The ACTH and Dex hypertension were partially reversed by folic acid.
|
17324744 |
2007 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Thus, NAC partially prevented but did not reverse ACTH-induced hypertension.
|
16546835 |
2006 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Thus, NAC partially prevented but did not reverse ACTH-induced hypertension.
|
16546835 |
2006 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Atorvastatin prevented and partially reversed adrenocorticotropic hormone-induced hypertension in the rat.
|
16620303 |
2006 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Atorvastatin prevented and partially reversed adrenocorticotropic hormone-induced hypertension in the rat.
|
16620303 |
2006 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
This result indicates that the cardiac glycoside binding site of the alpha1 isoform can also mediate ACTH-induced hypertension.
|
16243970 |
2005 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
This result indicates that the cardiac glycoside binding site of the alpha1 isoform can also mediate ACTH-induced hypertension.
|
16243970 |
2005 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Apocynin (but not allopurinol) co-treatment prevented (142+/-3 ACTH, 120+/-4 mm Hg apocynin+ACTH, P'<0.001) and reversed ACTH-induced hypertension (133+/-4 to 118+/-5 mm Hg, P<.05).
|
16053986 |
2005 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Apocynin (but not allopurinol) co-treatment prevented (142+/-3 ACTH, 120+/-4 mm Hg apocynin+ACTH, P'<0.001) and reversed ACTH-induced hypertension (133+/-4 to 118+/-5 mm Hg, P<.05).
|
16053986 |
2005 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
We hypothesized that ACTH-induced hypertension in the rat is characterized by increased EPO production.
|
15110907 |
2004 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Nitric oxide donation lowers blood pressure in adrenocorticotrophic hormone-induced hypertensive rats.
|
15554453 |
2004 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
BEFREE |
PNAH was associated with cushingoid features, virilization and hypertension with a lack of cortisol suppression on high DST, undetectable plasma ACTH and absent cortisol and ACTH responses to CRH.
|
15521956 |
2004 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Nitric oxide donation lowers blood pressure in adrenocorticotrophic hormone-induced hypertensive rats.
|
15554453 |
2004 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Accordingly we hypothesized that ACTH-induced hypertension would be reversed by BH4 supplementation.
|
15132301 |
2004 |
|
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
We hypothesized that ACTH-induced hypertension in the rat is characterized by increased EPO production.
|
15110907 |
2004 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Accordingly we hypothesized that ACTH-induced hypertension would be reversed by BH4 supplementation.
|
15132301 |
2004 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat.
|
12872045 |
2003 |
|
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Lipopolysaccharide reverses adrenocorticotrophic hormone-induced hypertension in the rat.
|
12887135 |
2003 |